* (Pharmacy Faculty Profile)

Kevin Cowart, PharmD, MPH, BCACP, CDCES

Assistant Professor, Taneja College of Pharmacy

Assistant Professor, Morsani College of Medicine

Assistant Professor, College of Public Health

Contact Info

12901 Bruce B. Downs Blvd. MDC 30
Tampa FL 33612
Academic Email: kcowart2@usf.edu
Academic Phone: (813) 974-5562

Education

PGY-2, Ambulatory Care Pharmacy Residency, University of Florida/UF Health, 2017
PGY-1, Pharmacy Residency, Duke University Health System, 2016
MPH, Epidemiology, University of Florida, 2015
PharmD, Pharmacy, University of South Florida, 2015
BS, Biomedical Sciences, University of South Florida, 2010

Research Interests

I explore interdisciplinary and technology-driven approaches to improving care for people with diabetes. As a pharmacist and diabetes educator, with training in epidemiology, my long-term research goal is to implement programs to advance pharmacy practice in primary care settings.

Recent Publications

Durell N, Franks R, Coon S, Cowart K, Carris NW. Effect of Antidepressants on Glucagon-Like Peptide-1 Receptor Agonist-Related Weight Loss. Journal of Pharmacy Technology. 38(5) : 283-288, 2022.
Cowart K, Zgibor J. Flash Continuous Glucose Monitoring: A Practical Guide and Call to Action for Pharmacists. Journal of Pharmacy Practice. 35(4) : 638-646, 2022.
Cowart K, Emechebe N, Pathak R, Abbruzese L, Hann J, Lloyd A, Roetzheim R, Zgibor J, Updike WH. Measurement of Pharmacist-Physician Collaborative Care on Therapeutic Inertia in Patients With Type 2 Diabetes. The Annals of Pharmacotherapy. 56(2) : 155-161, 2022.
Cowart K, Gonzalez R, Carris NW. Cardiovascular and microvascular outcomes with iGlarLixi versus iDegLira: A real-world, population-based cohort study. Diabetes, Obesity & Metabolism. 24(2) : 348-353, 2022.
Cowart K, Carris NW. Practicable Measurement and Identification of Overbasalization. Clinical Diabetes. 40(1) : 75-77, 2022.
Cheon B, Kumar A, Tsalatsanis A, Cowart K, Magness RR, Tipparaju SM, Carris NW. Impact of Metformin on Statin Persistence: a Post Hoc Analysis of a Large Randomized Controlled Trial. Journal of General Internal Medicine. 37(1) : 277-279, 2022.
Cowart K Franks RB Pane O Murphy E Oldziej . Addressing Overbasalization to Achieve Glycemic Targets ADCES in Practice. 10(2) : 277-279, 2022.
Cowart K, Patel V, Bianco J, Martinez A, Castro J. Pharmacist-Physician Collaborative Practice to Improve Diabetes Care at Tampa General Medical Group. Clinical Diabetes. 40(2) : 240-244, 2022.
Cowart K, Updike WH, Franks R. Continuous glucose monitoring in persons with type 2 diabetes not using insulin. Expert Review of Medical Devices. 18(11) : 1049-1055, 2021.
Cowart K, Carris NW. Continuous Glucose Monitoring and Glycemic Control in Patients With Type 2 Diabetes Treated With Basal Insulin. JAMA. 326(13) : 1329-1330, 2021.
Cowart K. Expanding Flash Continuous Glucose Monitoring Technology to a Broader Population. Clinical Diabetes. 39(3) : 320-322, 2021.
Updike WH, Cowart K, Woodyard JL, Serag-Bolos E, Taylor JR, Curtis SD. Protecting the Integrity of the Virtual Objective Structured Clinical Examination. American Journal of Pharmaceutical Education. 85(6) : 8438, 2021.
Cowart K, Updike WH, Pathak R. Prevalence of and Characteristics Associated With Overbasalization Among Patients With Type 2 Diabetes Using Basal Insulin: A Cross-Sectional Study. Clinical Diabetes. 39(2) : 173-175, 2021.
Carris NW, Cowart KM, Garcia AS. Ambulatory Care Pharmacists'' Perception of Prediabetes. Journal of Pharmacy Practice. 34(1) : 70-77, 2021.
Cowart K, Carris NW. Evaluation of cardiovascular and renal outcomes with ertugliflozin: what is the VERdict from the VERTIS-CV trial? Expert Opinion on Pharmacotherapy. 22(2) : 163-165, 2021.
Cowart K, Updike WH, Lloyd A, Bullers K. Anticipatory guidance and systematic review of prescribing combination incretin therapy in the treatment of type 2 diabetes. Journal of Clinical Pharmacy and Therapeutics. 46(1) : 28-34, 2021.
Cowart K. A Review of the First Long-term Implantable Continuous Glucose Monitoring System Available in the United States. Journal of Diabetes Science and Technology. 15(1) : 160-166, 2021.
Cowart K Updike W. Pharmacy student perception of a remote hypertension and drug information simulation-based learning experience in response to the SARS-CoV-2 pandemic Journal of the American College of Clinical Pharmacy. 4(1) : 53-59, 2021.
Cowart K. Flash Continuous Glucose Monitoring in Primary Care Settings: The Need for Measurement of Novel Glycemic Metrics to Adopt Policy and Practice Change. Journal of Managed Care & Specialty Pharmacy. 26(8) : 1050-1051, 2020.
Cowart K. Overbasalization: Addressing Hesitancy in Treatment Intensification Beyond Basal Insulin. Clinical Diabetes. 38(3) : 304-310, 2020.
Cowart K, Updike W, Emechebe N, Zgibor J. Using an Advanced Practice Pharmacist in a Team-Based Care Model to Decrease Time to Hemoglobin A Goal Among Patients With Type 2 Diabetes, Florida, 2017-2019. Preventing Chronic Disease. 17: E40, 2020.
Cowart K. Oral Semaglutide: First-in-Class Oral GLP-1 Receptor Agonist for the Treatment of Type 2 Diabetes Mellitus. The Annals of Pharmacotherapy. 54(5) : 478-485, 2020.
Cowart K, Updike W, Bullers K. Systematic Review of Randomized Controlled Trials Evaluating Glycemic Efficacy and Patient Satisfaction of Intermittent-Scanned Continuous Glucose Monitoring in Patients with Diabetes. Diabetes Technology & Therapeutics. 22(5) : 337-345, 2020.
Cowart K, Sando K. Pharmacist Impact on Treatment Intensification and Hemoglobin A in Patients With Type 2 Diabetes Mellitus at an Academic Health Center. Journal of Pharmacy Practice. 32(6) : 648-654, 2019.
Cowart K, Worley M, Rouby NE, Sando K. Evaluation of FDA Boxed Warning on Prescribing Patterns of Fluoroquinolones for Uncomplicated Urinary Tract Infections. The Annals of Pharmacotherapy. 53(12) : 1192-1199, 2019.
Tamargo C, Sando K, Prados Y, Cowart K. Change in Proportion of Days Covered for Statins Following Implementation of a Pharmacy Student Adherence Outreach Program. Journal of Managed Care & Specialty Pharmacy. 25(5) : 588-592, 2019.
Cowart K, Olson K. Impact of pharmacist care provision in value-based care settings: How are we measuring value-added services? Journal of the American Pharmacists Association. 59(1) : 125-128, 2019.
Cooper AA, Cowart K, Clayton A, Paul J. Undetectable Vancomycin Concentrations Utilizing a Particle Enhanced Turbidimetric Inhibition Immunoassay in a Patient with an Elevated IgM Level. Clinical Laboratory. 63(9) : 1527-1532, 2017.
Cowart K, Dell K, Rodriguez-Snapp N, Petrelli HM. An Examination of Correlations between MMI scores and Pharmacy School GPA. American Journal of Pharmaceutical Education. 80(6) : 98, 2016.